BHV Capital

BHV Partners functions as a venture builder focused on the health sector, creating startups by translating academic research into viable solutions. The firm bridges the gap between scientific discovery and commercialization, guiding promising intellectual property from universities and hospitals. Its core capability involves identifying groundbreaking innovations and building dedicated companies around these breakthroughs.

BHV Partners was founded in 2023 by experienced executives and scientists Marta Príncep, Albert Gimeno, Joaquim Trias, and Albert Mascarell. They identified a critical gap in commercializing pioneering academic and medical research. Their collective insight emphasized that scientific breakthroughs require dedicated entrepreneurial guidance and infrastructure to become impactful health enterprises.

BHV Partners supports academic researchers and institutions commercializing health innovations, ultimately delivering novel medical advancements to patients. The company's long-term vision is to accelerate innovative health company creation, enhancing the global healthcare landscape. They strive to be a pivotal force in translating groundbreaking health technologies from the laboratory to practical application.